EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Envoy Medical's enterprise value is $58.87 Mil.
Envoy Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-14.52 Mil. Therefore, Envoy Medical's EV-to-EBITDA for today is -4.05.
The historical rank and industry rank for Envoy Medical's EV-to-EBITDA or its related term are showing as below:
COCH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -9.93 Med: -2.86 Max: -0.88
Current: -4.05
During the past 3 years, the highest EV-to-EBITDA of Envoy Medical was -0.88. The lowest was -9.93. And the median was -2.86.
COCH's EV-to-EBITDA is ranked worse than 100% of 483
companies
in the Medical Devices & Instruments industry
Industry Median: 16.47
vs COCH: -4.05
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Envoy Medical EV-to-EBITDA Historical Data
The historical data trend for Envoy Medical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Envoy Medical's EV-to-EBITDA
For the Medical Devices subindustry, Envoy Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envoy Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Envoy Medical's EV-to-EBITDA falls into.
Envoy Medical EV-to-EBITDA Calculation
Envoy Medical's EV-to-EBITDA for today is calculated as:
Envoy Medical's current Enterprise Value is $58.87 Mil.
Envoy Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envoy Medical (NAS:COCH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Envoy Medical's PE Ratio for today is calculated as:
Envoy Medical's share price for today is $3.19.
Envoy Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.882.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Envoy Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Envoy Medical (Envoy Medical) Business Description
Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COCH has been successfully added to your